SpicyIP

NOVEMBER 15, 2022

the handles of INC and Bharat Jodo Yatra. The above DNRs are NameCheap Inc., Dynadot, LLC, Tucows Inc, Gransy s.r.o., Lt Foods Limited vs Saraswati Trading Company on 11 November, 2022 (Delhi High Court). Govt, and pharmaceutical companies to work together on pricing mechanism for off-patent drugs. Image from here.

Trademark 105

Trademark Patent Copyright Designs 105

LexBlog IP

OCTOBER 19, 2021

Eli Lilly and Company , Appeals 2020-1747, -1748, and -1750 (Fed. Sandoz Inc. , See, e.g., Juno Therapeutics, Inc. Kite Pharma, Inc. 26, 2021) (regarding claims to a chimeric antigen receptor (for a T cell) that includes any single-chain antibody fragments capable of binding any targets); Amgen Inc.

Invention 52

Invention Licensing Art Patent 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Several other companies have also announced plans to pursue interchangeable status for biosimilar products. Consistent with this, as shown below in Table 2, numerous companies have publicly announced the submission and/or acceptance of new biosimilar BLAs. Stimufend ® (Fresenius Kabi). Neulasta ® (Amgen). pegfilgrastim.

Litigation 52

Litigation Settlement Patent Marketing 52